Board of Directors
BerGenBio’s Board of Directors is composed of experienced biopharmaceutical executives with experience of developing next generation cancer drugs and building world class innovative oncology biotechnology companies. The Board also represents leading investors and has substantial commercial experience to navigate the development of the Company.
Mr. Anders Tullgren
Chair
Anders Tullgren joined the board in 2022 and has over…
Dr. Debra Barker
Non-Executive Director
Debra Barker joined the board in 2019 and is a…
Dr. Sally Bennett
Non-Executive Director
Dr Sally Bennett joined the board in 2020 and has…